 Press Release Distribution |
 |
- PR Home
- Latest News
- Feeds
- Alerts
- Submit Free Press Release
- Journalist Account
- PRNewswire Distribution
Filter News Show All ResultsNews By Country
News By Tag Epigenetics 
| epigenetics Latest News+ XML/RSSBy BPS Bioscience, Inc. Announcing the Availability of Methyl-Lysine Reader Proteins and Assay Kits for a New Class of Epigenetic Drug... By BPS Bioscience, Inc. BPS Bioscience, Inc. (“BPS”) announced the addition of 3 new assay kits (BRD9, CREBBP, and TRIM24) for identifying small molecule inhibitors of bromodomains (BRDs). By Zymo Research Zymo Research offers genome-wide Next-Gen sequencing services for genetic, epigenetic, and expression analysis By BioVision, Inc. BioVision recently introduced Nexturastat A, a highly potent and selective Histone Deacetylase 6 (HDAC6) inhibitor. This unique inhibitor is currently being marketed for research purposes exclusively by BioVision. By AnaSpec EGT Group Anti-5-Methylcyidine from Clone 33D3 can be used in applications such as Methylated DNA Immunoprecipitation (MeDIP), MeDIP-on-chip assay, immunofluorescence, flow cytometry and immunohistochemistry By Sara Pierre - Communication Manager tebu-bio is pleased to announce their agreement with CH3 BioSystems to distribute their product range to the European market. All Press ReleasesBy BPS Bioscience, Inc. Announcing the Availability of Methyl-Lysine Reader Proteins and Assay Kits for a New Class of Epigenetic Drug... By BPS Bioscience, Inc. BPS Bioscience, Inc. (“BPS”) announced the addition of 3 new assay kits (BRD9, CREBBP, and TRIM24) for identifying small molecule inhibitors of bromodomains (BRDs). By Zymo Research Zymo Research offers genome-wide Next-Gen sequencing services for genetic, epigenetic, and expression analysis By ReportReserve ReportReserve announces the inclusion of its new report published by Global Kalorama Information. By BioVision, Inc. BioVision recently introduced Nexturastat A, a highly potent and selective Histone Deacetylase 6 (HDAC6) inhibitor. This unique inhibitor is currently being marketed for research purposes exclusively by BioVision. By AnaSpec EGT Group Anti-5-Methylcyidine from Clone 33D3 can be used in applications such as Methylated DNA Immunoprecipitation (MeDIP), MeDIP-on-chip assay, immunofluorescence, flow cytometry and immunohistochemistry By Sara Pierre - Communication Manager tebu-bio is pleased to announce their agreement with CH3 BioSystems to distribute their product range to the European market. By Sara Pierre - Communication Manager Bromodomains are a new emerging class of pharmaceutical targets in the field of Epigenetics. Bromodomains (BRDs) are protein domains involved in Epigenetics that recognize acetylated lysines. By Russ Curran Jus International is holding a unique event -- A Blueprint for Abundant Living -- being held at Boston’s Marriott Copley Hotel on January 15, 2011, at 7 p.m. By AnaSpec AnaSpec, Eurogentec Group is pleased to offer anti-5-methylcytidine (Clone 33D3), Eurogentec’s most popular monoclonal antibody, for use in epigenetics research. By AbboMax, inc. AbboMax offers nine novel anti- histone H3 antibodies specific for a mono-, di-, or tri-methylated state of Lys4, Lys9, and Lys27 for the epigenetics research. . By Insight Pharma Reports CHI’s makes available its Insight Pharma Report on current and projected markets for epigenetic diagnostic and therapeutic products. By Mary Ann Liebert, Inc., publishers Increasing numbers of research studies clearly demonstrate that genetics alone cannot explain the diversity of living organisms, reports Genetic Engineering & Biotechnology News (GEN). By Joe Walsh Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report that presents information about the quickly emerging worldwide epigenetics market. | ||||||||||||||||||||||
Like PRLog?
8.4K1.9K2.6K